Abstract
BackgroundPrevious studies1–2 suggest the structural benefit of IV abatacept in patients with RA who have previously failed MTX, TNF therapy or combination of both.ObjectivesThis study evaluates the structural effect of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
